Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk's IT company to look at independent listing
Reuters
Wednesday, January 15, 2014 - 9:32am
tags:
Novo Nordisk, IPOs, IT
Chelsea Wins U.S. Panel’s Backing for Northera
Bloomberg
Wednesday, January 15, 2014 - 9:29am
tags:
Chelsea Therapeutics, FDA, advisory panels, Northera, neurogenic orthostatic hypotension
Glaxo Says China Sales Improved Since Third Quarter Drop
Bloomberg
Wednesday, January 15, 2014 - 9:27am
tags:
GSK, China
Arena Pharmaceuticals: 4 Different Insiders Have Sold Shares This Year
Seeking Alpha
Wednesday, January 15, 2014 - 9:24am
tags:
Arena Pharmaceuticals
Israeli Biotech New Issues Set A Blistering Pace
Investors.com
Wednesday, January 15, 2014 - 9:06am
tags:
Enzymotec, Kamada, Oramed Pharmaceuticals, Alcobra
Purdue Pharma Loses OxyContin Patent Trial Against Teva
Bloomberg
Wednesday, January 15, 2014 - 8:59am
tags:
Purdue Pharma, oxycontin, patents, Teva Pharmaceuticals
Illumina, Regeneron, Intuitive Q4 Results Impress
Investors.com
Wednesday, January 15, 2014 - 8:58am
tags:
earnings, Illumina, Regeneron, Intuitive Surgical
Teva sees U.S. approval of three times weekly Copaxone soon
Reuters
Tuesday, January 14, 2014 - 4:32pm
tags:
Teva, FDA, Copaxone, MS, multiple sclerosis
Jazz Pharma Acquires Sleep Drug
Yahoo/Zacks.com
Tuesday, January 14, 2014 - 4:31pm
tags:
Jazz Pharmaceuticals, ADX-N05, Aerial BioPharma, narcolepsy
FDA Okays VIVO's Flu Assay, Shares Up
Yahoo/Zacks.com
Tuesday, January 14, 2014 - 4:29pm
tags:
flu assay, FDA, H7N9, TRU FLU
Avanir Gives Preliminary Q1 Update
Yahoo/Zacks.com
Tuesday, January 14, 2014 - 4:27pm
tags:
Avanir, earnings
LipoScience Facing A Long, Hard Slog
Seeking Alpha
Tuesday, January 14, 2014 - 4:26pm
tags:
LipoScience, NMR LipoProfile
Merck needs a dose of joie de vivre, research chief says
Yahoo/Reuters
Tuesday, January 14, 2014 - 11:56am
tags:
Merck, Roger Perlmutter
[video] Biogen Has Many `Exciting' Drugs in Pipeline: CEO
Bloomberg
Tuesday, January 14, 2014 - 11:55am
tags:
Biogen Idec, George Scangos
Intuitive rises on 4Q sales, procedure outlook
Yahoo/AP
Tuesday, January 14, 2014 - 11:53am
tags:
Intuitive Surgical, earnings
Standard Review for Gilead's Oncology Candidate
Yahoo/Zacks.com
Tuesday, January 14, 2014 - 11:52am
tags:
Gilead Sciences, Idelalisib, refractory indolent non-Hodgkins lymphoma
The Short Story Of Intercept Pharmaceuticals (Part I): A Conference Call With Expert Physicians
Seeking Alpha
Tuesday, January 14, 2014 - 10:44am
tags:
Intercept Pharma, physicians, OCA
Packaging Defect Leads Merck To Recall All Lots of Liptruzet In US
Forbes
Tuesday, January 14, 2014 - 10:34am
tags:
recalls, Merck, Liptruzet
Valeant, Actavis, Mylan eye Pfizer's generics unit
Reuters
Tuesday, January 14, 2014 - 10:06am
tags:
generics, Pfizer, M&A, Valeant Pharmaceuticals, Actavis, Mylan
Ten things to know about the 2013 biotech IPO market
Changing Business of Life Sciences
Tuesday, January 14, 2014 - 10:03am
tags:
IPOs, biotech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.